We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

TERUMO

Terumo develops, manufactures and distributes medical devices, including a broad array of syringes, hypodermic needle... read more Featured Products: More products

Download Mobile App




New Oxygenator Improves Cardiopulmonary Bypass Care

By HospiMedica International staff writers
Posted on 29 Jan 2019
A novel oxygenator helps minimize the impact of cardiopulmonary bypass by reducing hemodilution, minimizing inflammatory response, and providing highly efficient gaseous microemboli (GME) removal.

The Terumo Cardiovascular Group (Ann Arbor, MI, USA) Capiox NX19 Oxygenator with UltraPrime Technology is intended for the exchange of gases between bloodcells and a gaseous environment, in order to satisfy the oxygenation needs of adult patients during cardiopulmonary bypass surgery. More...
An integrated arterial filter removes non-biologic particles and emboli and facilitates air bubble removal from the blood flowing through the cardiopulmonary bypass circuit. In addition, an integrated heat exchanger is used to warm or cool blood and/or perfusion fluid as it flows through the device.

A hardshell reservoir stores blood during extra-corporeal circulation, with a venous section comprised of a filter and defoamer to facilitate air bubble removal, and a cardiotomy section that contains a filter to remove particulate matter, as well as an additional defoamer. The technology is based on proprietary hollow fibers woven in a unique pattern, providing a low priming volume of just 185 mL, thus delivering high gas exchange performance without increasing pressure drop. The low priming volume also reduces hemodilution, leading to fewer blood transfusions and lower risk of acute kidney injury (AKI).

“The Capiox NX19 oxygenator is the next step in Terumo's legacy of oxygenator innovation,” said Robert De Ryke, President and CEO of Terumo Cardiovascular Group. “Terumo introduced the world's first hollow fiber oxygenator in 1982 and remains at the forefront of the industry, developing high quality products that help save patient lives.”

Cardiopulmonary bypass is a is a form of extracorporeal circulation that temporarily takes over the function of the heart and lungs during surgery, maintaining the circulation of blood and the oxygen content of the body. The cardiopulmonary bypass pump, often referred to as a heart–lung machine, is operated by perfusionists.

Related Links:
Terumo Cardiovascular Group


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Bipolar Coagulation Generator
Aesculap
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The 3D-printed microneedle patch boosts live-virus vaccine delivery (Photo courtesy of IIS/University of Tokyo)

3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.